BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 22608712)

  • 21. Neuropsychological Genotype-Phenotype in Patients with Williams Syndrome with Atypical Deletions: A Systematic Review.
    Serrano-Juárez CA; Prieto-Corona B; Rodríguez-Camacho M; Sandoval-Lira L; Villalva-Sánchez ÁF; Yáñez-Téllez MG; López MFR
    Neuropsychol Rev; 2023 Dec; 33(4):891-911. PubMed ID: 36520254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models.
    Kopp N; McCullough K; Maloney SE; Dougherty JD
    Hum Mol Genet; 2019 Oct; 28(20):3443-3465. PubMed ID: 31418010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biallelic GTF2IRD1 variants in brothers with profound neurodevelopmental disorder: A possible novel disorder involving a critical gene for Williams syndrome.
    Cummings CT; Starr LJ
    Am J Med Genet A; 2023 Feb; 191(2):332-337. PubMed ID: 36308390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation of Gtf2ird1 from the Williams-Beuren syndrome critical region results in facial dysplasia, motor dysfunction, and altered vocalisations.
    Howard ML; Palmer SJ; Taylor KM; Arthurson GJ; Spitzer MW; Du X; Pang TY; Renoir T; Hardeman EC; Hannan AJ
    Neurobiol Dis; 2012 Mar; 45(3):913-22. PubMed ID: 22198572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essential role of the N-terminal region of TFII-I in viability and behavior.
    Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
    BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism.
    Palmer SJ; Santucci N; Widagdo J; Bontempo SJ; Taylor KM; Tay ES; Hook J; Lemckert F; Gunning PW; Hardeman EC
    J Biol Chem; 2010 Feb; 285(7):4715-24. PubMed ID: 20007321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.
    Sakurai T; Dorr NP; Takahashi N; McInnes LA; Elder GA; Buxbaum JD
    Autism Res; 2011 Feb; 4(1):28-39. PubMed ID: 21328569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
    Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
    Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consistent hypersocial behavior in mice carrying a deletion of
    Martin LA; Iceberg E; Allaf G
    Brain Behav; 2018 Jan; 8(1):e00895. PubMed ID: 29568691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurodevelopmental and behavioral issues in Williams syndrome.
    Paterson SJ; Schultz RT
    Curr Psychiatry Rep; 2007 Apr; 9(2):165-71. PubMed ID: 17389129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contribution of GTF2I haploinsufficiency to Williams syndrome.
    Chailangkarn T; Noree C; Muotri AR
    Mol Cell Probes; 2018 Aug; 40():45-51. PubMed ID: 29305905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of GTF2IRD1 in the auditory pathology of Williams-Beuren Syndrome.
    Canales CP; Wong AC; Gunning PW; Housley GD; Hardeman EC; Palmer SJ
    Eur J Hum Genet; 2015 Jun; 23(6):774-80. PubMed ID: 25248400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of GTF2IRD1, a putative transcription factor within the Williams-Beuren syndrome deletion at 7q11.23.
    Franke Y; Peoples RJ; Francke U
    Cytogenet Cell Genet; 1999; 86(3-4):296-304. PubMed ID: 10575229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A transcription factor involved in skeletal muscle gene expression is deleted in patients with Williams syndrome.
    Tassabehji M; Carette M; Wilmot C; Donnai D; Read AP; Metcalfe K
    Eur J Hum Genet; 1999; 7(7):737-47. PubMed ID: 10573005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.
    Pérez Jurado LA; Wang YK; Peoples R; Coloma A; Cruces J; Francke U
    Hum Mol Genet; 1998 Mar; 7(3):325-34. PubMed ID: 9466987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TFII-I gene family during tooth development: candidate genes for tooth anomalies in Williams syndrome.
    Ohazama A; Sharpe PT
    Dev Dyn; 2007 Oct; 236(10):2884-8. PubMed ID: 17823943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Williams-Beuren syndrome: a model of recurrent genomic mutation.
    Pérez Jurado AL
    Horm Res; 2003; 59 Suppl 1():106-13. PubMed ID: 12638521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population.
    Crespi BJ; Hurd PL
    BMC Neurosci; 2014 Nov; 15():127. PubMed ID: 25429715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Gtf2ird1, the Williams syndrome-associated gene, during mouse development.
    Palmer SJ; Tay ES; Santucci N; Cuc Bach TT; Hook J; Lemckert FA; Jamieson RV; Gunnning PW; Hardeman EC
    Gene Expr Patterns; 2007 Feb; 7(4):396-404. PubMed ID: 17239664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atypical deletions in Williams-Beuren syndrome].
    Ramírez-Velazco A; Domínguez-Quezada MG
    Rev Med Inst Mex Seguro Soc; 2017; 55(5):615-620. PubMed ID: 29193944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.